I have no position for ethical reasons, as an eye surgeon, but I have been dropping in on the board as I am concerned it will go under. The treatment of OM with melphalan using the delcath system is by far the best treatment out there for metastatic disease. There is only one other immune treatment that even comes close, and it is by study only. Once approved, the treatment can be used off label for any other tumor metastatic to the liver.
I hope it makes it, but am not optimistic......it is apparent that further dilution is in store for current shareholders because they do not have the money to get where they need to go for the FDA....but I'm just an outsider looking in